4//SEC Filing
CUMBERLAND PHARMACEUTICALS INC 4
Accession 0001209191-16-113791
$CPIXCIK 0001087294operating
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 6:14 PM ET
Size
6.2 KB
Accession
0001209191-16-113791
Insider Transaction Report
Form 4
Lawrence Thomas R
Director
Transactions
- Award
Common Stock
2016-04-06$4.34/sh+6,000$26,040→ 51,381 total - Sale
Common Stock
2016-03-17$4.34/sh−5,000$21,700→ 45,381 total
Footnotes (2)
- [F1]Shares sold to Cumberland Pharmaceuticals Inc.
- [F2]Restricted stock award will vest 100% on March 18, 2017.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeoperating
IncorporatedTN
Related Parties
1- filerCIK 0001087294
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 6:14 PM ET
- Size
- 6.2 KB